December 19, 2025

MIND study collaborators convene at UW to discuss future directions for childhood neurodevelopment research

MIND meeting collaborators at the University of Washington

Earlier this month, the Drug, microbiome, and immune determinants of birth and neurodevelopmental outcomes in children with exposure to HIV infection (MIND) study collaborators based at the University of Washington convened for a day of knowledge sharing and discussions on projects focusing on adverse birth and neurodevelopmental outcomes in young children exposed to HIV but are uninfected (CHEU).

Following the recent funding of the Researching Interventions and Implementation Strategies to Evaluate the Health and Development of Children Affected by HIV (RISE) Program, collaborators discussed implementation science considerations for neurodevelopmental screening and interventions. They also shared observations and findings to date about influential factors, such as neuroimaging markers of cognition in people living with HIV, prenatal PrEP exposure, toxic environmental exposures, on neurodevelopmental outcomes Some project findings to date may provide a strong foundation for competitive future grant applications and expanded funding opportunities.

The UW MIND team plans to report back to other study collaborators to continue advancing this important work in 2026.